| Truncations of titin causing dilated cardiomyopathy DS Herman, L Lam, MRG Taylor, L Wang, P Teekakirikul, ... New England Journal of Medicine 366 (7), 619-628, 2012 | 1421 | 2012 |
| Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy CY Ho, B López, OR Coelho-Filho, NK Lakdawala, AL Cirino, P Jarolim, ... New England Journal of Medicine 363 (6), 552-563, 2010 | 690 | 2010 |
| Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial I Olivotto, A Oreziak, R Barriales-Villa, TP Abraham, A Masri, ... The Lancet 396 (10253), 759-769, 2020 | 632 | 2020 |
| Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe) CY Ho, SM Day, EA Ashley, M Michels, AC Pereira, D Jacoby, AL Cirino, ... Circulation 138 (14), 1387-1398, 2018 | 552 | 2018 |
| Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy CY Ho, NK Sweitzer, B McDonough, BJ Maron, SA Casey, JG Seidman, ... Circulation 105 (25), 2992-2997, 2002 | 479 | 2002 |
| A clinician’s guide to tissue Doppler imaging CY Ho, SD Solomon Circulation 113 (10), e396-e398, 2006 | 443 | 2006 |
| Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity AA Alfares, MA Kelly, G McDermott, BH Funke, MS Lebo, SB Baxter, ... Genetics in medicine 17 (11), 880-888, 2015 | 419 | 2015 |
| Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy BJ Maron, WC Roberts, M Arad, TS Haas, P Spirito, GB Wright, ... Jama 301 (12), 1253-1259, 2009 | 367 | 2009 |
| Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations F Girolami, CY Ho, C Semsarian, M Baldi, ML Will, K Baldini, F Torricelli, ... Journal of the American College of Cardiology 55 (14), 1444-1453, 2010 | 344 | 2010 |
| Genetic evaluation of cardiomyopathy—a Heart Failure Society of America practice guideline RE Hershberger, MM Givertz, CY Ho, DP Judge, PF Kantor, KL McBride, ... Journal of Cardiac Failure 24 (5), 281-302, 2018 | 337 | 2018 |
| Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface SM Lewis, X Wu, A Pustilnik, A Sereno, F Huang, HL Rick, G Guntas, ... Nature biotechnology 32 (2), 191-198, 2014 | 282 | 2014 |
| Gene mutations in apical hypertrophic cardiomyopathy M Arad, M Penas-Lado, L Monserrat, BJ Maron, M Sherrid, CY Ho, S Barr, ... Circulation 112 (18), 2805-2811, 2005 | 282 | 2005 |
| T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy CY Ho, SA Abbasi, TG Neilan, RV Shah, Y Chen, B Heydari, AL Cirino, ... Circulation: Cardiovascular Imaging 6 (3), 415-422, 2013 | 253 | 2013 |
| Long-term arrhythmic and nonarrhythmic outcomes of lamin A/C mutation carriers S Kumar, SH Baldinger, E Gandjbakhch, P Maury, JM Sellal, ... Journal of the American college of cardiology 68 (21), 2299-2307, 2016 | 252 | 2016 |
| Genetic advances in sarcomeric cardiomyopathies: state of the art CY Ho, P Charron, P Richard, F Girolami, KY Van Spaendonck-Zwarts, ... Cardiovascular research 105 (4), 397-408, 2015 | 233 | 2015 |
| Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy CN Toepfer, AC Garfinkel, G Venturini, H Wakimoto, G Repetti, L Alamo, ... Circulation 141 (10), 828-842, 2020 | 223 | 2020 |
| The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance RA Noureldin, S Liu, MS Nacif, DP Judge, MK Halushka, TP Abraham, ... Journal of Cardiovascular Magnetic Resonance 14 (1), 12, 2012 | 222 | 2012 |
| Evaluation of mavacamten in symptomatic patients with nonobstructive hypertrophic cardiomyopathy CY Ho, ME Mealiffe, RG Bach, M Bhattacharya, L Choudhury, ... Journal of the American College of Cardiology 75 (21), 2649-2660, 2020 | 219 | 2020 |
| Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations V Sequeira, PJM Wijnker, LLAM Nijenkamp, DWD Kuster, A Najafi, ... Circulation research 112 (11), 1491-1505, 2013 | 214 | 2013 |
| Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) RE Hershberger, MM Givertz, CY Ho, DP Judge, PF Kantor, KL McBride, ... Genetics in Medicine 20 (9), 899-909, 2018 | 212 | 2018 |
